|
5-(2-Chlorophenyl)Furan-2-Carboxylic Acid
|
DB02909 |
|
|
2-Amino-Vinyl-Phosphate
|
DB02907 |
|
|
RU78783
|
DB02908 |
|
|
[(2r,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydro-2-Furanyl]Methyl Sulfamate
|
DB02916 |
|
|
N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide
|
DB02917 |
|
|
(6e)-6-[(2e,4e,6e)-3,7-Dimethylnona-2,4,6,8-Tetraenylidene]-1,5,5-Trimethylcyclohexene
|
DB02914 |
|
|
4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine
|
DB02915 |
|
|
Propanoyl-CoA
|
DB02912 |
|
|
Octanoyl-Coenzyme A
|
DB02910 |
|
|
2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine
|
DB02911 |
|
|
Emactuzumab
|
DB14905 |
[Emactuzumab is under investigation in clinical trial NCT01494688 (A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Participants With Advanced Solid Tumors).] |
|
Pimasertib
|
DB14904 |
[Pimasertib is under investigation in clinical trial NCT01378377 (Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus).] |
|
Bevacizumab zirconium Zr-89
|
DB14907 |
[Bevacizumab zirconium Zr-89 is under investigation in clinical trial NCT01338090 (89Zr-bevacizumab PET Imaging in Patients With Neuroendocrine Tumors).] |
|
Adafosbuvir
|
DB14906 |
[Adafosbuvir is under investigation in clinical trial NCT02894905 (A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of AL-335).] |
|
Inclisiran
|
DB14901 |
[Inclisiran is under investigation in clinical trial NCT03705234 (A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease).] |
|
ISO-1 F-18
|
DB14900 |
[ISO-1 F-18 is under investigation in clinical trial NCT00968656 (Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1).] |
|
Rovafovir etalafenamide
|
DB14903 |
[Rovafovir etalafenamide is under investigation in clinical trial NCT03472326 (Efficacy of GS-9131 Functional Monotherapy in HIV-1-Infected Adults Failing a Nucleos(t)Ide Reverse Transcriptase Inhibitor-Containing Regimen).] |
|
JHU-75528 C-11
|
DB14902 |
[JHU-75528 C-11 is under investigation in clinical trial NCT03204305 (Brain Imaging of Cannabinoid Receptors).] |
|
Zardaverine
|
DB02918 |
|
|
2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine
|
DB02919 |
|
